Zuwallack RL - Search Results

1

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.

Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R. Levin DC, et al. Among authors: zuwallack rl. Am J Med. 1996 Jan 29;100(1A):40S-48S. doi: 10.1016/s0002-9343(96)80073-8. Am J Med. 1996. PMID: 8610716 Clinical Trial.

2

Functional status in pulmonary rehabilitation participants.

Haggerty MC, Stockdale-Woolley R, ZuWallack R. Haggerty MC, et al. J Cardiopulm Rehabil. 1999 Jan-Feb;19(1):35-42. doi: 10.1097/00008483-199901000-00005. J Cardiopulm Rehabil. 1999. PMID: 10079419

3

Long-term benefits of short-stay inpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease.

Bowen JB, Thrall RS, ZuWallack RL, Votto JJ. Bowen JB, et al. Among authors: zuwallack rl. Monaldi Arch Chest Dis. 1999 Apr;54(2):189-92. Monaldi Arch Chest Dis. 1999. PMID: 10394839 Clinical Trial.

4

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.

Rennard SI, Anderson W, ZuWallack R, Broughton J, Bailey W, Friedman M, Wisniewski M, Rickard K. Rennard SI, et al. Am J Respir Crit Care Med. 2001 Apr;163(5):1087-92. doi: 10.1164/ajrccm.163.5.9903053. Am J Respir Crit Care Med. 2001. PMID: 11316640 Clinical Trial.

5

Salmeterol plus theophylline combination therapy in the treatment of COPD.

ZuWallack RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K. ZuWallack RL, et al. Chest. 2001 Jun;119(6):1661-70. doi: 10.1378/chest.119.6.1661. Chest. 2001. PMID: 11399688 Clinical Trial.

6

An evaluation of nebulized levalbuterol in stable COPD.

Datta D, Vitale A, Lahiri B, ZuWallack R. Datta D, et al. Chest. 2003 Sep;124(3):844-9. Chest. 2003. PMID: 12970007 Clinical Trial.

7

Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.

Celli B, ZuWallack R, Wang S, Kesten S. Celli B, et al. Chest. 2003 Nov;124(5):1743-8. doi: 10.1378/chest.124.5.1743. Chest. 2003. PMID: 14605043 Clinical Trial.

8

Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease.

ZuWallack RL, Haggerty MC, Jones P. ZuWallack RL, et al. Am J Med. 2004 Dec 20;117 Suppl 12A:49S-59S. doi: 10.1016/j.amjmed.2004.10.020. Am J Med. 2004. PMID: 15693643 Review.

9

Measuring unsupported arm lifts as an outcome in pulmonary rehabilitation of chronic obstructive pulmonary disease patients.

Datta D, ZuWallack RL. Datta D, et al. Among authors: zuwallack rl. Chron Respir Dis. 2013 Aug;10(3):159-63. doi: 10.1177/1479972313497371. Chron Respir Dis. 2013. PMID: 23897931 Free article.

10

Physical activity as a predictor of thirty-day hospital readmission after a discharge for a clinical exacerbation of chronic obstructive pulmonary disease.

Chawla H, Bulathsinghala C, Tejada JP, Wakefield D, ZuWallack R. Chawla H, et al. Ann Am Thorac Soc. 2014 Oct;11(8):1203-9. doi: 10.1513/AnnalsATS.201405-198OC. Ann Am Thorac Soc. 2014. PMID: 25167366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters